|
시장보고서
상품코드
1831765
임상 검사 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 최종용도별, 지역별 - 예측(2025-2034년)Clinical Laboratory Tests Market Size, Share, Trends, & Industry Analysis Report By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 임상 검사 시장 규모는 2034년까지 2,871억 2,000만 달러에 이를 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.
임상 검사는 건강상태를 평가하고, 이상을 검출하고, 의료상의 의사결정을 이끌기 위해 수행되는 체계적인 진단평가로 정의됩니다. 효율성, 정확성, 납기를 향상시키는 검사실 업무에 있어서의 자동화와 디지털 기술의 통합의 고조가 시장 확대의 원동력이 되고 있습니다. 자동 분석기, AI 주도 데이터 분석, 첨단 인포매틱스 시스템은 워크플로우를 간소화하고 인위적 실수를 줄여 진단의 신뢰성을 높입니다. 이러한 기술적 변화는 환자의 결과를 개선하고 현대 건강 관리 시스템에서 높은 처리량 검사에 대한 수요 증가에도 대응하고 있습니다.
임상 검사 시장은 개별 환자 프로파일에 맞는 고급 진단 방법을 필요로 하는 개인화된 의료에 대한 관심 증가에 의해 견인되고 있습니다. 임상 검사는 바이오마커, 유전적 소인, 치료반응의 동정에 중심적인 역할을 하여 표적 치료를 지원하고 있습니다. Precision Health Care의 도입이 진행됨에 따라 일상적인 진단에 그치지 않는 전문적이고 방대한 검사에 대한 수요가 높아지고 있습니다. 이러한 환자 중심 솔루션으로의 전환은 효과적이고 맞춤화된 의료를 제공하는 검사 서비스의 전략적 중요성을 강화하고 있습니다.
임상 검사 시장 보고서 하이라이트
유형별로는 HbA1c 검사 분야가 2024년에 16.42%의 매출 점유율을 차지했으며, 당뇨병 이환율의 상승과 장기적인 포도당 모니터링에 대한 주목 증가에 견인되었습니다.
최종 용도별로, 포인트 오브 케어 검사에 대한 수요와 진단 액세스의 개선에 의해 1차 클리닉 부문은 CAGR 8.6%의 견고한 성장이 예측됩니다.
북미는 첨단 인프라와 새로운 진단 기술의 채택으로 2024년 세계 시장 점유율은 40.47%의 시장 점유율을 차지했습니다.
아시아태평양 시장은 도시화와 헬스케어 지출 증가에 견인되어 2025년부터 2034년에 걸쳐 CAGR 9.7%를 보일 것으로 예측됩니다.
세계 주요 시장 기업은 Abbott Laboratories, ARUP Laboratories, Biosino Bio-Technology and Science Inc., Charles River Laboratories, Fresenius Medical Care, Genoptix, Inc., Healthscope Ltd., Laboratory Corporation of America Holdings(LabCorp), Neck Inc., OPKO Health, Inc., QIAGEN, Quest Diagnostics, Siemens Healthineers AG, Sonic Healthcare, Tulip Diagnostics(P) Ltd. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 임상 검사 시장 인사이트
- 임상 검사 - 업계 개요
- 임상 검사 시장 역학
- 성장 촉진요인과 기회
- 임상 검사에 있어서의 급속한 혁신
- 고령화 인구 증가와 대상 질환의 유병률의 상승
- 억제요인과 과제
- 고액의 수속 비용과 모호한 규제 틀의 존재
- 성장 촉진요인과 기회
- Porter's Five Forces
- 공급기업의 협상력(보통)
- 신규 진입의 위협(보통)
- 구매자의 협상력(높음)
- 대체품의 위협(낮음)
- 기존 기업 간의 경쟁(높음)
- 정치, 경제, 사회, 기술(PEST) 분석
- COVID-19의 영향 분석과 업계 동향
제5장 임상 검사 시장의 평가 : 유형별
- 소개
- 완전혈구수
- HGB/HCT
- 기초 대사 패널
- BUN 크레아티닌 검사
- 전해질 검사
- HbA1c 검사
- 종합 대사 패널
- 간 패널
- 신장 패널
- 지질 패널
제6장 임상 검사 시장 평가 : 최종 용도별
- 소개
- 중앙연구소
- 1차 클리닉
제7장 임상 검사 시장 평가 : 지역별
- 소개
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 오스트리아
- 아시아태평양
- 중국
- 인도
- 일본
- 인도네시아
- 말레이시아
- 한국
- 라틴아메리카
- 브라질
- 멕시코
- 중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
제8장 기업 프로파일
- Abbott Laboratories
- ARUP Laboratories
- OPKO Health, Inc.
- NeoGenomics Laboratories, Inc.
- Genoptix, Inc.
- Healthscope Ltd.
- Laboratory Corporation of America Holdings(LabCorp)
- Fresenius Medical Care
- Quest Diagnostics
- Sonic Healthcare
- QIAGEN
- Siemens Healthineers AG
- Merck KgaA
- Tulip Diagnostics(P) Ltd.
- Biosino Bio-Technology and Science Inc.
- Charles River Laboratories
The clinical laboratory tests market size is expected to reach USD 287.12 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Clinical laboratory tests are defined as systematic diagnostic evaluations conducted to assess health status, detect abnormalities, and guide medical decisions. The rising integration of automation and digital technologies in laboratory operations, which enhances efficiency, accuracy, and turnaround times, drives the market expansion. Automated analyzers, AI-driven data interpretation, and advanced informatics systems are streamlining workflows and reducing human errors, making diagnostics more reliable. This technological transformation improves patient outcomes and also addresses the growing demand for high-throughput testing in modern healthcare systems.
The clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.
Clinical Laboratory Tests Market Report Highlights
In terms of type, the HbA1c tests segment held a 16.42% revenue share in 2024, driven by rising diabetes rates and a growing focus on long-term glucose monitoring.
Based on end use, the primary clinics segment is projected to grow at a robust 8.6% CAGR, driven by demand for point-of-care testing and better diagnostic access.
North America held a dominant 40.47% global market share in 2024, due to its advanced infrastructure and adoption of new diagnostic technologies.
The Asia Pacific market is forecasted to grow at a 9.7% CAGR from 2025 to 2034, driven by urbanization and increasing healthcare spending.
A few global key market players include Abbott Laboratories; ARUP Laboratories; Biosino Bio-Technology and Science Inc.; Charles River Laboratories; Fresenius Medical Care; Genoptix, Inc.; Healthscope Ltd.; Laboratory Corporation of America Holdings (LabCorp); Merck KgaA; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; QIAGEN; Quest Diagnostics; Siemens Healthineers AG; Sonic Healthcare; and Tulip Diagnostics (P) Ltd.
Polaris Market Research has segmented the market report on the basis of type, end use, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Complete Blood Count
HGB/HCT
Basic Metabolic Panel
BUN Creatinine Tests
Electrolytes Testing
HbA1c Tests
Comprehensive Metabolic Panel
Liver Panel
Renal Panel
Lipid Panel
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Central Laboratories
Primary Clinics
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
Chapter 1. Introduction
- 1.1 Report Description
- 1.1.1 Objectives of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
- 1.2 Stakeholders
Chapter 2. Executive Summary
Chapter 3. Research Methodology
- 3.1 Overview
- 3.1.1 Data Mining
- 3.2 Data Sources
- 3.2.1 Primary Sources
- 3.2.2 Secondary Sources
Chapter 4. Clinical Laboratory Tests Market Insights
- 4.1 Clinical Laboratory Tests - Industry snapshot
- 4.1 Clinical Laboratory Tests Market Dynamics
- 4.1.1 Drivers and Opportunities
- 4.1.1.1 Rapid innovations in the Clinical Laboratory Tests
- 4.1.1.2 Rising Geriatric Population and Rising Prevalence Of Target Diseases
- 4.1.2 Restraints and Challenges
- 4.1.2.1 High Procedure Costs and Presence of Ambiguous Regulatory Framework
- 4.1.1 Drivers and Opportunities
- 4.2 Clinical Laboratory Tests Market - Porter's Five Forces
- 4.2.1 Bargaining Power of Suppliers (Moderate)
- 4.2.2 Threats of New Entrants: (Moderate)
- 4.2.3 Bargaining Power of Buyers (High)
- 4.2.4 Threat of Substitute (Low)
- 4.2.5 Rivalry among existing firms (High)
- 4.3 Political, Economic, Social, and Technological (PEST) Analysis
- 4.4 Covid-19 Impact Analysis & Industry Trends
Chapter 5. Clinical Laboratory Tests Market Assessment by Type
- 5.1 Introduction
- 5.2 Complete Blood Count
- 5.3 HGB/HCT
- 5.4 Basic Metabolic Panel
- 5.5 BUN Creatinine Tests
- 5.6 Electrolytes Testing
- 5.7 HbA1c Tests
- 5.8 Comprehensive Metabolic Panel
- 5.9 Liver Panel
- 5.10 Renal Panel
- 5.11 Lipid Panel
Chapter 6. Clinical Laboratory Tests Market Assessment by End-Use
- 6.1 Introduction
- 6.2 Central Laboratories
- 6.3 Primary Clinics
Chapter 7. Clinical Laboratory Tests Market Assessment by Region
- 7.1 Introduction
- 7.2 Clinical Laboratory Tests Market - North America
- 7.2.1 Clinical Laboratory Tests Market - U.S.
- 7.2.2 Clinical Laboratory Tests Market - Canada
- 7.3 Clinical Laboratory Tests Market - Europe
- 7.3.1 Clinical Laboratory Tests Market - Germany
- 7.3.2 Clinical Laboratory Tests Market - UK
- 7.3.3 Clinical Laboratory Tests Market - France
- 7.3.4 Clinical Laboratory Tests Market - Italy
- 7.3.5 Clinical Laboratory Tests Market - Spain
- 7.3.6 Clinical Laboratory Tests Market - Netherlands
- 7.3.7 Clinical Laboratory Tests Market - Austria
- 7.4 Clinical Laboratory Tests Market - Asia Pacific
- 7.4.1 Clinical Laboratory Tests Market - China
- 7.4.2 Clinical Laboratory Tests Market - India
- 7.4.3 Clinical Laboratory Tests Market - Japan
- 7.4.4 Clinical Laboratory Tests Market - Indonesia
- 7.4.5 Clinical Laboratory Tests Market - Malaysia
- 7.4.6 Clinical Laboratory Tests Market - South Korea
- 7.5 Clinical Laboratory Tests Market - Latin America
- 7.5.1 Clinical Laboratory Tests Market - Brazil
- 7.5.2 Clinical Laboratory Tests Market - Mexico
- 7.6 Clinical Laboratory Tests Market - Middle East & Africa
- 7.6.1 Clinical Laboratory Tests Market - Saudi Arabia
- 7.6.2 Clinical Laboratory Tests Market - UAE
Chapter 8. Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Business Overview
- 8.1.2 Financial Snapshot
- 8.1.3 Products and Services
- 8.1.4 Recent Developments
- 8.2 ARUP Laboratories
- 8.2.1 Business Overview
- 8.2.2 Products and Services
- 8.2.3 Recent Developments
- 8.3 OPKO Health, Inc.
- 8.3.1 Business Overview
- 8.3.2 Financial Snapshot
- 8.3.3 Products and Services
- 8.3.4 Recent Developments
- 8.4 NeoGenomics Laboratories, Inc.
- 8.4.1 Business Overview
- 8.4.2 Financial Snapshot
- 8.4.3 Products and Services
- 8.4.4 Recent Developments
- 8.5 Genoptix, Inc.
- 8.5.1 Business Overview
- 8.5.2 Products and Services
- 8.6 Healthscope Ltd.
- 8.6.1 Business Overview
- 8.6.2 Products and Services
- 8.7 Laboratory Corporation of America Holdings (LabCorp)
- 8.7.1 Business Overview
- 8.7.2 Financial Snapshot
- 8.7.3 Products and Services
- 8.7.4 Recent Developments
- 8.8 Fresenius Medical Care
- 8.8.1 Business Overview
- 8.8.2 Financial Snapshot
- 8.8.3 Products and Services
- 8.8.4 Recent Developments
- 8.9 Quest Diagnostics
- 8.9.1 Business Overview
- 8.9.2 Financial Snapshot
- 8.9.3 Products and Services
- 8.9.4 Recent Developments
- 8.10 Sonic Healthcare
- 8.10.1 Business Overview
- 8.10.2 Financial Snapshot
- 8.10.3 Products and Services
- 8.11 QIAGEN
- 8.11.1 Business Overview
- 8.11.2 Financial Snapshot
- 8.11.3 Products and Services
- 8.12 Siemens Healthineers AG
- 8.12.1 Business Overview
- 8.12.2 Financial Snapshot
- 8.12.3 Products and Services
- 8.13 Merck KgaA
- 8.13.1 Business Overview
- 8.13.2 Financial Snapshot
- 8.13.3 Products and Services
- 8.14 Tulip Diagnostics (P) Ltd.
- 8.14.1 Business Overview
- 8.14.2 Products and Services
- 8.14.3 Recent Developments
- 8.15 Biosino Bio-Technology and Science Inc.
- 8.15.1 Business Overview
- 8.15.2 Financial Snapshot
- 8.15.3 Products and Services
- 8.16 Charles River Laboratories
- 8.16.1 Business Overview
- 8.16.2 Financial Snapshot
- 8.16.3 Products and Services
